Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Assets: 2009-2021

Historic Return on Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -0.31%.

  • Avadel Pharmaceuticals' Return on Assets fell 41.00% to -0.34% in Q4 2021 from the same period last year, while for Dec 2021 it was -0.34%, marking a year-over-year decrease of 41.00%. This contributed to the annual value of -0.31% for FY2021, which is 28.00% down from last year.
  • According to the latest figures from FY2021, Avadel Pharmaceuticals' Return on Assets is -0.31%, which was down 1,021.49% from -0.03% recorded in FY2020.
  • Avadel Pharmaceuticals' Return on Assets' 5-year high stood at 0.27% during FY2017, with a 5-year trough of -0.44% in FY2019.
  • In the last 3 years, Avadel Pharmaceuticals' Return on Assets had a median value of -0.31% in 2021 and averaged -0.26%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Return on Assets spiked by 45bps in 2017 and then tumbled by 70bps in 2018.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Return on Assets stood at 0.27% in 2017, then tumbled by 70bps to -0.43% in 2018, then declined by 2bps to -0.44% in 2019, then surged by 42bps to -0.03% in 2020, then decreased by 28bps to -0.31% in 2021.